Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Event, Product/Service, Award, Contest

Announcing iMFLUX Auto Viscosity Adjusttm 2022 Edison Award Finalist in Sustainability


The Edison Awards globally recognizes, honors and fosters innovators and innovations that positively impact the world. As a 2022 Edison Award Finalist iMFLUX is thrilled to be included among this elite group of finalists recognized for excellence in innovation.

Specifically, Auto Viscosity Adjust was nominated in the category of Sustainability and will medal in the Plastic Upcycling during the gala event, April 20-22, 2022. Hosted by journalist Miles O'Brien from PBS NewsHour, this year's Edison Awards will be held at the Luminary Hotel in Ft. Myers, Florida.

Edison Award attendees will have the opportunity to witness new products and services while learning from several of today's greatest innovators. Innovators like the 2022 Edison Achievement Award Honorees, Carmichael Roberts, Material Impact and Breakthrough Energy Ventures and Bracken Darrell, Logitech will be in attendance along with the team behind iMFLUX's Auto Viscosity Adjust (AVA), a product that is a game changer because AVA adapts to changing injection molding conditions including highly variable post consumer resin (PCR). AVA provides this sustainability solution at scale, which is unavailable in conventional molding.

Frank Bonafilia, Edison Awards' executive director, stated, "It's exciting to see companies like iMFLUX continuing Thomas Edison's legacy of challenging conventional thinking." We are honored Auto Viscosity Adjust is in league with that of Thomas Edison's innovations?a man who transformed our world and created a meaningful impact on the future through designs such as incandescent electric light and the system of electrical power, the phonograph and recorded sound, the telephone transmitter, the storage battery, as well as movies and the motion-picture camera.

The Edison Awards is a program conducted by Edison Universe, a 501(c)(3) charitable organization. If you are curious about invention, visit a complete list of 2022 finalist innovations at: https://edisonawards.com/finalists2022.php

About iMFLUX

iMFLUX (a wholly owned subsidiary of Procter & Gamble) is a software and engineering innovation company that partners with leaders in the plastics industry, injection molding machine manufacturers, injection molding customers and resin suppliers, delivering significant, sustainable competitive advantage in their market segments. iMFLUX's core technical competencies include polymer processing, machine control software and hardware, mold design and fabrication, materials expertise, metrology & analytics and industrial design. This unique combination of technical expertise all under one roof provides our customers with a one-stop solution to some of the most challenging engineering challenges the industry faces. www.imflux.com.


These press releases may also interest you

at 14:33
Enabled Intelligence (EI), a global leader in mission-critical AI data solutions for the US Defense and Intelligence Community today announced a groundbreaking new partnership with Melwood, a leading employer, advocate, and service provider for...

at 14:23
Autolomous, the market-leading developer of critical manufacturing management systems for cell and gene therapies, and BioCentriq, industry-leading clinical-phase Cell Therapy CDMO (contract development and manufacturing organization), announce a...

at 14:08
Seacoast Laboratory Data Systems, a nationwide leader in providing customizable LIS and AR software solutions for commercial and...

at 14:05
Transflo, a leading provider of technology solutions for the transportation industry, is thrilled to announce that it has won three 2024 Top Workplaces Culture Excellence awards. The honors are awarded by Energage, a purpose-driven organization that...

at 14:05
Coalition, the world's first Active Insurance provider designed to prevent digital risk before it strikes, today published its 2024 Cyber Claims Report, which details emerging cyber trends and their impact on Coalition policyholders throughout 2023....

at 14:04
Today, the U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and...



News published on and distributed by: